CAS: 125068-54-4 - NSP 805
Fórmula:C17H19N3O2
InChI:InChI=1/C17H19N3O2/c1-10-9-16(22)19-20-17(10)12-3-5-13(6-4-12)18-14-7-8-15(21)11(14)2/h3-6,10,18H,7-9H2,1-2H3,(H,19,22)
- Sinónimos:
- 4,5-Dihydro-5-methyl-6-(4-((2-methyl-3-oxo-1-cyclopentenyl)amino)phenyl)-3-(2H)-pyridazinone
- 3(2H)-Pyridazinone, 4,5-dihydro-5-methyl-6-(4-((2-methyl-3-oxo-1-cyclopenten-1-yl)amino)phenyl)-
- 5-methyl-6-{4-[(2-methyl-3-oxocyclopent-1-en-1-yl)amino]phenyl}-4,5-dihydropyridazin-3(2H)-one
- Nsp-805
- Nsp 805
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
NSP-805 REF: TM-T12267CAS: 125068-54-4 | 99.10% | 51,00 €~2.124,00 € | Jue 12 Dic 24 | |
3(2H)-Pyridazinone, 4,5-dihydro-5-methyl-6-[4-[(2-methyl-3-oxo-1-cyclopenten-1-yl)amino]phenyl]- REF: IN-DA000N32CAS: 125068-54-4 | 99% | A consultar | Jue 12 Dic 24 | |
NSP-805 REF: 3D-AFA06854CAS: 125068-54-4 | Min. 95% | A consultar | Jue 23 Ene 25 |
NSP-805
CAS:125068-54-4
NSP-805 is a potent and selective guinea pig cardiac phosphodiesterase 3 (PDE3) inhibitor.
Fórmula:
C17H19N3O2
Pureza:
99.10%
Forma y color:
Solid
Peso molecular:
297.35
Ref: TM-T12267
1mg | 51,00 € | ||
5mg | 112,00 € | ||
10mg | 181,00 € | ||
25mg | 315,00 € | ||
50mg | 450,00 € | ||
100mg | 621,00 € | ||
200mg | 840,00 € | ||
1mL*10mM (DMSO) | 124,00 € |
Entrega estimada en Estados Unidos, el Jueves 12 de Diciembre de 2024
3(2H)-Pyridazinone, 4,5-dihydro-5-methyl-6-[4-[(2-methyl-3-oxo-1-cyclopenten-1-yl)amino]phenyl]-
CAS:125068-54-4
Fórmula:
C17H19N3O2
Pureza:
99%
Forma y color:
Solid
Peso molecular:
297.3517
Ref: IN-DA000N32
1mg | 149,00 € | ||
5mg | 316,00 € | ||
10mg | 506,00 € | ||
25mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 12 de Diciembre de 2024
NSP-805
CAS:125068-54-4
NSP-805 is a calcium antagonist with inotropic and vasodilatory properties. It has been shown to …
Fórmula:
C17H19N3O2
Pureza:
Min. 95%
Peso molecular:
297.35 g/mol
Ref: 3D-AFA06854
25mg | A consultar | ||
50mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 23 de Enero de 2025